Taar1 gene variants have a causal role in methamphetamine intake and response and interact with Oprm1
Abstract
We identified a locus on mouse chromosome 10 that accounts for 60% of the genetic variance in methamphetamine intake in mice selectively bred for high versus low methamphetamine consumption. We nominated the trace amine-associated receptor 1 gene, Taar1, as the strongest candidate and identified regulation of the mu-opioid receptor 1 gene, Oprm1, as another contributor. This study exploited CRISPR-Cas9 to test the causal role of Taar1 in methamphetamine intake and a genetically-associated thermal response to methamphetamine. The methamphetamine-related traits were rescued, converting them to levels found in methamphetamine-avoiding animals. We used a family of recombinant inbred mouse strains for interval mapping and to examine independent and epistatic effects of Taar1 and Oprm1. Both methamphetamine intake and the thermal response mapped to Taar1 and the independent effect of Taar1 was dependent on genotype at Oprm1. Our findings encourage investigation of the contribution of Taar1 and Oprm1 variants to human methamphetamine addiction.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2 through 8.
Article and author information
Author details
Funding
National Institute on Drug Abuse (R01 DA046081)
- Tamara J Phillips
Veterans Affairs Research Career Scientist Program (Career Scientist award)
- Tamara J Phillips
Veterans Affairs Research Career Scientist Program (Career Scientist award)
- Aaron J Janowsky
University of Tennessee Center for Integrative and Translational Science (Center support)
- Robert W Williams
National Institute on Drug Abuse (P50 DA018165)
- Aaron J Janowsky
National Institute on Drug Abuse (P50 DA018165)
- Tamara J Phillips
National Institute on Drug Abuse (U01 DA041579)
- Tamara J Phillips
National Institute on Drug Abuse (P30 DA044223)
- Robert W Williams
Department of Veterans Affairs (I01BX002106)
- Tamara J Phillips
Department of Veterans Affairs (I01BX002758)
- Aaron J Janowsky
Department of Veterans Affairs (I01BX003279)
- Kim A Neve
Oregon Health & Science University-Pilot Funding to the Transgenic Mouse Models Shared Resource (University Shared Resource award)
- Kim A Neve
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.
Reviewing Editor
- Jonathan Flint, University of California, Los Angeles, United States
Ethics
Animal experimentation: All experiments were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the VA Portland Health Care System (VAPORHCS), protocol numbers 3169-14 and 3169-16.
Version history
- Received: February 28, 2019
- Accepted: July 4, 2019
- Accepted Manuscript published: July 5, 2019 (version 1)
- Accepted Manuscript updated: July 9, 2019 (version 2)
- Version of Record published: August 5, 2019 (version 3)
Copyright
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Metrics
-
- 2,090
- Page views
-
- 461
- Downloads
-
- 21
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Genetics and Genomics
Endothelial cell subpopulations are characterized by unique gene expression profiles, epigenetic landscapes and functional properties.
-
- Genetics and Genomics
- Immunology and Inflammation
Periodontitis drives irreversible destruction of periodontal tissue and is prone to exacerbating inflammatory disorders. Systemic immunomodulatory management continues to be an attractive approach in periodontal care, particularly within the context of ‘predictive, preventive, and personalized’ periodontics. The present study incorporated genetic proxies identified through genome-wide association studies for circulating immune cells and periodontitis into a comprehensive Mendelian randomization (MR) framework. Univariable MR, multivariable MR, subgroup analysis, reverse MR, and Bayesian model averaging (MR-BMA) were utilized to investigate the causal relationships. Furthermore, transcriptome-wide association study and colocalization analysis were deployed to pinpoint the underlying genes. Consequently, the MR study indicated a causal association between circulating neutrophils, natural killer T cells, plasmacytoid dendritic cells, and an elevated risk of periodontitis. MR-BMA analysis revealed that neutrophils were the primary contributors to periodontitis. The high-confidence genes S100A9 and S100A12, located on 1q21.3, could potentially serve as immunomodulatory targets for neutrophil-mediated periodontitis. These findings hold promise for early diagnosis, risk assessment, targeted prevention, and personalized treatment of periodontitis. Considering the marginal association observed in our study, further research is required to comprehend the biological underpinnings and ascertain the clinical relevance thoroughly.